This shouldn’t come as news to marijuana users: Stereotypes regarding cannabis are often wrong. Research by GW Pharmaceuticals and the University of Buckingham in the United Kingdom has shown that some of the compounds found in marijuana can have a beneficial effect for people suffering from metabolic diseases associated with obesity.
In animal trials, it was discovered in 2012 that these compounds acted as appetite suppressants, lowered cholesterol, decreased fat buildup, and improved insulin response to sugars. These qualities could be used to reduce the risk of diabetes, heart disease, and stroke associated with obesity, as well as aid in weight management programs.
GW Pharmaceuticals is already working in the U.K. on a variety of marijuana-based drugs for the treatment of multiple sclerosis, epilepsy, cancer pain, and other conditions.
But back in the United States, most other research into the medical properties of marijuana has been stalled, thanks to the policies of the federal government, which discourages medical marijuana research and will only fund studies looking for dangers of cannabis, as opposed to its benefits.